05.07.21

Johnson & Johnson Vision Announces FDA Approval Of Tecnis Synergy And Tecnis Synergy Toric II IOLs In the US

Source: Johnson & Johnson Vision

Johnson & Johnson Vision announced the FDA approval of Tecnis Synergy and Tecnis Synergy Toric II IOLs, and the Health Canada approval of Tecnis Synergy Toric II IOLs.

This next-generation PCIOL is built on the legacy Tecnis platform and delivers a wide range of continuous vision with the best near vision among leading PCIOLs, according to Johnson & Johnson Vision.3,4,6,7,8 † The lens also provides superior contrast even in low-light conditions, and reduced spectacle wear.1,2,3,4,8 In a company sponsored study, 9 out of 10 patients who received Tecnis Synergy IOL lenses did not need glasses after surgery.9 ††

“In the past 10 months of implanting the Tecnis Synergy IOL lens, I have seen excellent visual performance at all distances, and in a wide variety of lighting conditions, with most patients achieving freedom from glasses,” Ike Ahmed, MD, Assistant Professor and Director of the Glaucoma and Advanced Anterior Surgical Fellowship, University of Toronto in Canada, said in a company news release. “Having used the Tecnis Toric II platform in other Tecnis lenses, I’m eager to use the Tecnis Synergy Toric II IOL in patients that require astigmatism correction.”

The Tecnis Synergy and Tecnis Synergy Toric II IOLs are among the latest surgical vision innovations from Johnson & Johnson Vision to receive FDA and Health Canada approval. Over the past year, the company has received clearance or approval across North America for seven innovations designed to be used in the treatment of cataract patients, including the Tecnis Eyhance IOLs.

“The Tecnis Synergy IOL combines the best of extended depth of focus and multifocal technologies—to deliver the widest range of continuous vision with the best near vision among leading PCIOLs, without the visual gaps caused by existing trifocal technology,” said Rajesh Rajpal, Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision. “Additionally, we’ll offer Tecnis Synergy IOL on our new Toric II platform, when it launches later this year, to give surgeons the ability to address astigmatism at the time of surgery.”

The Tecnis Synergy IOL was first launched in Europe and Asia Pacific in 2019 and is currently available in Latin America and Canada. The full Tecnis Synergy IOL family will be available across North America this summer. 

References

† vs PanOptix® IOL, Symfony, TMF Continuous 20/32 or better based on defocus curve (United States), vs. PanOptix® IOL, AT Lisa Trifocal IOL and FineVision IOL (Canada)

[1] TECNIS Synergy™ IOL with TECNIS Simplicity Delivery System DFU, Z311421E

[2] DOF2019OTH4002 – Weeber H. MTF of the TECNIS SynergyTM OptiBlue® IOL, and other lens models. 27 Mar 2019.

[3] DOF2019OTH4005 – Perez G. Simulated VA of the TECNIS SynergyTM IOL and AT Lisa Tri IOL. 5 May 2019.

[4] DOF2019OTH4006 – Perez G. Simulated VA of the TECNIS SynergyTM IOL and FineVision IOL. 5 May 2019

[5] DOF2020CT4015- (“Forte 1”): A Comparative Clinical Evaluation of a New TECNIS® Presbyopia Correcting Intraocular Lens Against a PanOptix® Intraocular Lens-SPECTACLE WEAR AND SATISFACTION RESULTS

[6] TECNIS® Multifocal 1-Piece IOL ZKB00 and ZLB00 DfU – US – Doc. #Z311328. Rev. A, 04/2018. REF2019CT4049.

[7] DOF2020CT4014 – Forte 1: A Comparative Clinical Evaluation of a New TECNIS® Presbyopia Correcting Intraocular Lens Against a PanOptix® Intraocular Lens- Defocus Curves and Visual Acuity Results

[8] TECNIS Symfony™ Extended Range of Vision IOL DfU – OUS – Doc. #Z311278. Rev. 01, 02/2018. REF2018CT4277.

[9] DOF2020CT4015- (“Forte 1”): A Comparative Clinical Evaluation of a New TECNIS® Presbyopia Correcting Intraocular Lens Against a PanOptix® Intraocular Lens-SPECTACLE WEAR AND SATISFACTION RESULTS

[10] World Health Organization. Blindness and Impairment. https://www.who.int/en/news-room/fact-sheets/detail/blindness-and-visual-impairment

[11] University of Michigan Kellogg Eye Center website. http://www.kellogg.umich.edu/patientcare/conditions/cataract.html. Accessed October 28, 2017. REF2016OTH0327

 

Related Content